
Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS
Keywords: Mucopolysaccharidosis نوع II; Cerebrospinal fluid; LC/MS/MS; Enzyme replacement therapy; Glycosaminoglycan; Iduronate-2-sulfatase; Mucopolysaccharidosis type II;